Skip to main content
Top
Published in: Pituitary 5/2017

Open Access 01-10-2017

Pituitary dysfunction in granulomatosis with polyangiitis

Authors: Daniela Esposito, Penelope Trimpou, Dario Giugliano, Mats Dehlin, Oskar Ragnarsson

Published in: Pituitary | Issue 5/2017

Login to get access

Abstract

Purpose

Granulomatosis with polyangiitis (GPA) is a multisystem disease, characterized by necrotizing small-vessel vasculitis, which mainly affects the respiratory tract and the kidneys. Pituitary involvement in GPA is rare, present in about 1% of all cases of GPA. To date, only case reports or small case series have been published. Herein we report clinical features, imaging findings, treatment and outcomes in three patients with GPA-related pituitary dysfunction (PD).

Methods

A retrospective analysis of three cases of GPA-related PD was conducted, followed by systematic review of the English medical literature using PubMed.

Results

The three cases include three women aged between 32 and 37 years. PD was the presenting feature in one and two developed PD in the course of the disease. All patients had a pituitary lesion on MRI. Conventional treatment with high doses of glucocorticoids and cyclophosphamide led to resolution or improvement of the MRI abnormalities, whereas it was not effective in restoring PD. A systematic review identified 51 additional patients, showing that GPA can lead to partial or global PD, either at onset or, during the course of the disease. Secondary hypogonadism is the predominant manifestation, followed by diabetes insipidus (DI). Sellar mass with central cystic lesion is the most frequent radiological finding.

Conclusion

GPA should be carefully considered in patients with a sellar mass and unusual clinical presentation with DI and systemic disease. Although conventional induction-remission treatment improves systemic symptoms and radiological pituitary abnormalities, hormonal deficiencies persist in most of the patients. Therefore, follow-up should include both imaging and pituitary function assessment.
Literature
2.
go back to reference Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr, et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33(8):1101–1107CrossRefPubMed Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr, et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33(8):1101–1107CrossRefPubMed
3.
go back to reference Kapoor E, Cartin-Ceba R, Specks U, Leavitt J, Erickson B, Erickson D (2014) Pituitary dysfunction in granulomatosis with polyangiitis: the Mayo Clinic experience. J Clin Endocrinol Metab 99(11):3988–3994. doi:10.1210/jc.2014-1962 CrossRefPubMed Kapoor E, Cartin-Ceba R, Specks U, Leavitt J, Erickson B, Erickson D (2014) Pituitary dysfunction in granulomatosis with polyangiitis: the Mayo Clinic experience. J Clin Endocrinol Metab 99(11):3988–3994. doi:10.​1210/​jc.​2014-1962 CrossRefPubMed
4.
go back to reference Ahlstrom CG, Liedholm K, Truedsson E (1953) Respirato-renal type of polyarteritis nodosa. Acta Med Scand 144(5), 323–332CrossRefPubMed Ahlstrom CG, Liedholm K, Truedsson E (1953) Respirato-renal type of polyarteritis nodosa. Acta Med Scand 144(5), 323–332CrossRefPubMed
5.
go back to reference Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ (1999) Pituitary involvement by Wegener’s granulomatosis: a report of two cases. AJNR Am J Neuroradiol 20(3):519–523PubMed Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ (1999) Pituitary involvement by Wegener’s granulomatosis: a report of two cases. AJNR Am J Neuroradiol 20(3):519–523PubMed
6.
go back to reference Garovic VD, Clarke BL, Chilson TS, Specks U (2001) Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener’s granulomatosis. Am J Kidney Dis 37(1):E5CrossRefPubMed Garovic VD, Clarke BL, Chilson TS, Specks U (2001) Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener’s granulomatosis. Am J Kidney Dis 37(1):E5CrossRefPubMed
7.
go back to reference Miesen WM, Janssens EN, van Bommel EF (1999) Diabetes insipidus as the presenting symptom of Wegener’s granulomatosis. Nephrol Dial Transplant 14(2), 426–429CrossRefPubMed Miesen WM, Janssens EN, van Bommel EF (1999) Diabetes insipidus as the presenting symptom of Wegener’s granulomatosis. Nephrol Dial Transplant 14(2), 426–429CrossRefPubMed
8.
go back to reference Tappouni R, Burns A (2000) Pituitary involvement in Wegener’s granulomatosis. Nephrol Dial Transplant 15(12), 2057–2058CrossRefPubMed Tappouni R, Burns A (2000) Pituitary involvement in Wegener’s granulomatosis. Nephrol Dial Transplant 15(12), 2057–2058CrossRefPubMed
10.
go back to reference Rosete A, Cabral AR, Kraus A, Alarcon-Segovia D (1991) Diabetes insipidus secondary to Wegener’s granulomatosis: report and review of the literature. J Rheumatol 18(5):761–765PubMed Rosete A, Cabral AR, Kraus A, Alarcon-Segovia D (1991) Diabetes insipidus secondary to Wegener’s granulomatosis: report and review of the literature. J Rheumatol 18(5):761–765PubMed
11.
go back to reference De Parisot A, Puechal X, Langrand C, Raverot G, Gil H, Perard L, Le Guenno G, Berthier S, Tschirret O, Eschard JP, Vinzio S, Guillevin L, Seve P, French Vasculitis Study, G (2015) Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature. Medicine 94(16):e748. doi:10.1097/MD.0000000000000748 CrossRefPubMedPubMedCentral De Parisot A, Puechal X, Langrand C, Raverot G, Gil H, Perard L, Le Guenno G, Berthier S, Tschirret O, Eschard JP, Vinzio S, Guillevin L, Seve P, French Vasculitis Study, G (2015) Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature. Medicine 94(16):e748. doi:10.​1097/​MD.​0000000000000748​ CrossRefPubMedPubMedCentral
12.
go back to reference Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488–498CrossRefPubMed Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116(6):488–498CrossRefPubMed
16.
go back to reference Sautner D, Saeger W, Ludecke DK, Jansen V, Puchner MJ (1995) Hypophysitis in surgical and autoptical specimens. Acta Neuropathol 90(6):637–644CrossRef Sautner D, Saeger W, Ludecke DK, Jansen V, Puchner MJ (1995) Hypophysitis in surgical and autoptical specimens. Acta Neuropathol 90(6):637–644CrossRef
17.
go back to reference Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE (1993) Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 33(1):4–9. doi:10.1002/ana.410330103 CrossRefPubMed Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE (1993) Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 33(1):4–9. doi:10.​1002/​ana.​410330103 CrossRefPubMed
19.
go back to reference Arnaud L, Nordin A, Lundholm H, Svenungsson E, Hellbacher E, Wikner J, Zickert A, Gunnarsson I (2017) Effect of corticosteroids and cyclophosphamide on sex hormone profiles in male patients with Systemic lupus erythematosus and Systemic sclerosis. Arthritis Rheumatol. doi:10.1002/art.40057 PubMed Arnaud L, Nordin A, Lundholm H, Svenungsson E, Hellbacher E, Wikner J, Zickert A, Gunnarsson I (2017) Effect of corticosteroids and cyclophosphamide on sex hormone profiles in male patients with Systemic lupus erythematosus and Systemic sclerosis. Arthritis Rheumatol. doi:10.​1002/​art.​40057 PubMed
20.
go back to reference Ho KK, Participants, G.H.D.C.W (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157(6):695–700. doi:10.1530/EJE-07-0631 CrossRefPubMed Ho KK, Participants, G.H.D.C.W (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157(6):695–700. doi:10.​1530/​EJE-07-0631 CrossRefPubMed
23.
go back to reference Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CM, St Clair EW, Ikle D, Tchao NK, Ding L, Brunetta P, Choi HK, Monach PA, Fervenza F, Stone JH, Specks U, R-IR Group (2016) Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis 75(6):1166–1169. doi:10.1136/annrheumdis-2015-208073 CrossRefPubMed Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CM, St Clair EW, Ikle D, Tchao NK, Ding L, Brunetta P, Choi HK, Monach PA, Fervenza F, Stone JH, Specks U, R-IR Group (2016) Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis 75(6):1166–1169. doi:10.​1136/​annrheumdis-2015-208073 CrossRefPubMed
24.
go back to reference Kronbichler A, Jayne DR (2015) Con: should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab? Nephrol Dial Transplant 30(7), 1075–1081. doi:10.1093/ndt/gfv216 CrossRefPubMed Kronbichler A, Jayne DR (2015) Con: should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab? Nephrol Dial Transplant 30(7), 1075–1081. doi:10.​1093/​ndt/​gfv216 CrossRefPubMed
26.
go back to reference Olsson DS, Bryngelsson IL, Ragnarsson O (2016) Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study. Eur J Endocrinol 175(1):55–61. doi:10.1530/EJE-16-0173 CrossRefPubMed Olsson DS, Bryngelsson IL, Ragnarsson O (2016) Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study. Eur J Endocrinol 175(1):55–61. doi:10.​1530/​EJE-16-0173 CrossRefPubMed
Metadata
Title
Pituitary dysfunction in granulomatosis with polyangiitis
Authors
Daniela Esposito
Penelope Trimpou
Dario Giugliano
Mats Dehlin
Oskar Ragnarsson
Publication date
01-10-2017
Publisher
Springer US
Published in
Pituitary / Issue 5/2017
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-017-0811-0

Other articles of this Issue 5/2017

Pituitary 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine